|
Revenue from operations jumped 29.7% year on year to Rs 1252.98 crore in Q4 FY23.
Profit before tax increased 36.6% to Rs 17.25 crore in Q4 FY23 from Rs 12.63 crore in Q4 FY22.
EBITDA stood at Rs 406.2 crore in Q4 FY23, recording growth of 37.6% as compared with Rs 295.2 crore posted in corresponding quarter last year. EBITDA was at 3.2% in Q4 FY23 as against 3.1% in Q4 FY22.
During the quarter, the company said that its gross store additions stood at 284 stores.
On full year basis, the company's consolidated net profit declined 48.1% to Rs 49.76 crore despite of 20.6% jump in revenue from operations to Rs 4557.58 crore in FY23 over FY22.
Medplus Health Services is in the business of pathological laboratory testing and manufacturing, wholesale trading and contract manufacturing of pharma, fast-moving consumer goods and beauty products and rendering of management services to group companies and holds investments in subsidiary companies.
|